Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that...
13 insider purchases on record · latest filing 2025-07-30.
Insiders have also filed 1 sale transaction at LEXX.